Do you want to read an article? Please log in or register.
Real world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with HCV genotype 1 and 4
HepatitisHepatology
Related content
RECOMMENDED
Helicobacter Pylori
Review: Treatment of Helicobacter pylori Infection 2019
Helicobacter.
O'Connor A, Liou JM, Gisbert JP, O'Morain C
doi: 10.1111/hel.12640.
COMMENTED
Inflammatory Bowel Disease
Vedolizumab for the treatment of Non-Inflammatory Bowel Disease Related Enteropathy
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
Clin Gastroenterol Hepatol
Akhtar HJ, Nguyen TM, Ma C, Jairath V
doi: 10.1016/j.cgh.2021.02.026
Inflammatory Bowel Disease
Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn's Fistulas
Inflamm Bowel Dis.
Lightner AL, Dozois EJ, Dietz AB, Fletcher JG, Friton J, Butler G, Faubion WA
doi: 10.1093/ibd/izz215.
Hepatitis
Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis
J Hepatol
Loglio A, Ferenci P, Uceda Renteria SC, Tham CYL, Scholtes C, Holzmann H, van Bömmel F, Borghi M, Perbellini R, Rimondi A, Farina E, Trombetta E, Manunta M, Porretti L, Prati D, Ceriotti F, Zoulim F, Bertoletti A, Lampertico P
doi: 10.1016/j.jhep.2021.10.012
Helicobacter Pylori
Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis
Gut
Ford AC, Tsipotis E, Yuan Y, Leontiadis GI, Moayyedi P
doi: 10.1136/gutjnl-2021-326583